Clinical trial

Voriconazole Trough Plasma Levels : Genetic Polymorphism, Efficacy, Safety in Patients With Hematologic Malignancy

NCT01148160

StatusTERMINATED

Study typeOBSERVATIONAL

Start date2010-08-01

PhaseN/A

Study timeline

Study start (unknown)2010-08-01Date precision: month

Registry last updated2014-04-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Invasive Fungal Infectionunresolved

Interventions

voriconazoleDRUG · verified · RxNorm: voriconazole

Sponsors & collaborators

Asan Medical Centerlead sponsor

Mapped research locations

SeoulSouth Korea1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01148160 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.